文献速递乳腺癌放疗放疗物理与技术

乳腺癌/胸壁放疗后肺灌注下降的前瞻性定量研究

Decreased Lung Perfusion After Breast/Chest Wall Irradiation: Quantitative Results From a Prospective Clinical Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2016-10-19

该前瞻性临床试验纳入50例淋巴结阳性乳腺癌患者,在放疗前和放疗后1年进行SPECT/CT肺灌注扫描,评估乳腺/胸壁及区域淋巴结放疗后肺灌注变化,并按10 Gy剂量递增分析灌注下降与放疗剂量的关系。结果显示几乎所有患者左肺出现灌注下降,接受50-60 Gy区域灌注比值降至0.72(95%CI 0.64-0.79,P<.001),左肺每增加10 Gy灌注比值下降0.06(P<.001),但无患者出现肺毒性症状。

要点

  • 乳腺癌/胸壁放疗后SPECT/CT可见肺灌注下降,50-60 Gy区域灌注比值0.72。
  • 左肺每增加10 Gy,肺灌注比值下降0.06(P<.001)。
  • 尽管灌注下降,本组患者均未出现肺毒性症状。

核心结论

  • 乳腺癌/胸壁及区域淋巴结放疗后,SPECT/CT可定量显示肺灌注下降,且与放疗剂量相关。

研究设计与样本

  • 前瞻性临床试验纳入50例淋巴结阳性乳腺癌患者,放疗前后行SPECT/CT肺灌注扫描并配准分析。

主要发现

  • 几乎所有患者左肺出现灌注下降,50-60 Gy区域灌注比值0.72(95%CI 0.64-0.79,P<.001)。
  • 左肺每增加10 Gy,肺灌注比值下降0.06(P<.001)。
  • 无患者出现肺毒性症状。

关键数值与推荐

  • 乳腺/胸壁及区域淋巴结放疗剂量50-52.2 Gy,瘤床/手术瘢痕加量。
  • 按10 Gy剂量递增(0-60 Gy)计算平均灌注下降比值。

临床怎么用

  • 对淋巴结阳性乳腺癌放疗患者,可利用SPECT/CT定量评估肺灌注变化并与剂量分布关联。

局限性

  • 样本量50例,仅报告1年随访灌注结果,未出现症状性肺毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To quantify lung perfusion changes after breast/chest wall radiation therapy (RT) using pre- and post-RT single photon emission computed tomography/computed tomography (SPECT/CT) attenuation-corrected perfusion scans; and correlate decreased perfusion with adjuvant RT dose for breast cancer in a prospective clinical trial. METHODS AND MATERIALS: As part of an institutional review board-approved trial studying the impact of RT technique on lung function in node-positive breast cancer, patients received breast/chest wall and regional nodal irradiation including superior internal mammary node RT to 50 to 52.2 Gy with a boost to the tumor bed/mastectomy scar. All patients underwent quantitative SPECT/CT lung perfusion scanning before RT and 1 year after RT. The SPECT/CT scans were co-registered, and the ratio of decreased perfusion after RT relative to the pre-RT perfusion scan was calculated to allow for direct comparison of SPECT/CT perfusion changes with delivered RT dose. The average ratio of decreased perfusion was calculated in 10-Gy dose increments from 0 to 60 Gy. RESULTS: Fifty patients had complete lung SPECT/CT perfusion data available. No patient developed symptoms consistent with pulmonary toxicity. Nearly all patients demonstrated decreased perfusion in the left lung according to voxel-based analyses. The average ratio of lung perfusion deficits increased for each 10-Gy increment in radiation dose to the lung, with the largest changes in regions of lung that received 50 to 60 Gy (ratio 0.72 [95% confidence interval 0.64-0.79], P<.001) compared with the 0- to 10-Gy region. For each increase in 10 Gy to the left lung, the lung perfusion ratio decreased by 0.06 (P<.001). CONCLUSIONS: In the assessment of 50 patients with node-positive breast cancer treated with RT in a prospective clinical trial, decreased lung perfusion by SPECT/CT was demonstrated. Our study allowed for quantification of lung perfusion defects in a prospective cohort of breast cancer patients for whom attenuation-corrected SPECT/CT scans could be registered directly to RT treatment fields for precise dose estimates.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Liss AL, Marsh RB, Kapadia NS, et al. Decreased Lung Perfusion After Breast/Chest Wall Irradiation: Quantitative Results From a Prospective Clinical Trial. Int J Radiat Oncol Biol Phys. 2016. PMID: 27986344. doi:10.1016/j.ijrobp.2016.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。